Drug Shortage Report for DOBUTAMINE INJECTION USP
Report ID | 25930 |
Drug Identification Number | 02210401 |
Brand name | DOBUTAMINE INJECTION USP |
Common or Proper name | DOBUTAMINE |
Company Name | PFIZER CANADA ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | DOBUTAMINE |
Strength(s) | 12.5MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 10x20mL |
ATC code | C01CA |
ATC description | CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2017-11-15 |
Estimated end date | |
Actual end date | 2018-09-07 |
Shortage status | Resolved |
Updated date | 2018-09-08 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-10-13 | English | Compare |
v2 | 2017-10-13 | French | Compare |
v3 | 2017-10-13 | English | Compare |
v4 | 2017-10-13 | French | Compare |
v5 | 2017-12-06 | English | Compare |
v6 | 2017-12-06 | French | Compare |
v7 | 2017-12-14 | English | Compare |
v8 | 2017-12-14 | French | Compare |
v9 | 2018-01-25 | English | Compare |
v10 | 2018-01-25 | French | Compare |
v11 | 2018-04-17 | English | Compare |
v12 | 2018-04-17 | French | Compare |
v13 | 2018-06-11 | English | Compare |
v14 | 2018-06-11 | French | Compare |
v15 | 2018-07-30 | English | Compare |
v16 | 2018-07-30 | French | Compare |
v17 | 2018-09-07 | English | Compare |
v18 | 2018-09-07 | French | Compare |
v19 | 2018-09-08 | English | Compare |
Showing 1 to 19 of 19